First Food and Drug Administration approval under humanitarian device exemption of a septal occluder for fenestrated fontan and muscular ventricular septal defects (news)

Ruiz CE; Austin EH-3rd; Cheatham JP; Danford DA; Latson LA; Mayer J; Mullins CE; Sanders S

首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >First Food and Drug Administration approval under humanitarian device exemption of a septal occluder for fenestrated fontan and muscular ventricular septal defects (news)

【24h】

First Food and Drug Administration approval under humanitarian device exemption of a septal occluder for fenestrated fontan and muscular ventricular septal defects (news)

机译：首次获得食品和药物管理局批准，根据人道主义设备免除隔膜封堵器的有孔font门和肌肉性室间隔缺损（新闻）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Circulation: An Official Journal of the American Heart Association》 |2000年第21期|共1页
作者
Ruiz CE; Austin EH-3rd; Cheatham JP; Danford DA; Latson LA; Mayer J; Mullins CE; Sanders S;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类基础医学;
关键词
Fontan Procedure; Heart Septal Defects; Ventricular; FONTAN手术; 室间隔缺损;

机译：Fontan Procedure;Heart Septal Defects;Ventricular;FONTAN手术;室间隔缺损;

相似文献

外文文献
专利

1. First Food and Drug Administration approval under humanitarian device exemption of a septal occluder for fenestrated fontan and muscular ventricular septal defects (news) [J] . Ruiz CE, Austin EH-3rd, Cheatham JP, Circulation: An Official Journal of the American Heart Association . 2000,第21期

机译：首次获得食品和药物管理局批准，根据人道主义设备免除隔膜封堵器的有孔font门和肌肉性室间隔缺损（新闻）
2. Retrograde approach for device closure of muscular ventricular septal defects in children and adolescents, using the Amplatzer muscular ventricular septal defect occluder. [J] . Jameel AA, Arfi AM, Arif H, Pediatric cardiology . 2006,第6期

机译：使用Amplatzer肌室间隔缺损封堵器，逆行闭合儿童和青少年肌室间隔缺损的装置。
3. Retrograde Approach for Device Closure of Muscular Ventricular Septal Defects in Children and Adolescents, Using the Amplatzer Muscular Ventricular Septal Defect Occluder [J] . Al-Ata Jameel, Amin Muhammed Arfi, Hussain Arif, Pediatric Cardiology . 2006,第6期

机译：使用Amplatzer肌室间隔缺损封堵器逆行闭合儿童和青少年的肌室间隔缺损的方法
4. FINITE ELEMENT MODELING AND ANALYSIS OF VENTRICULAR SEPTAL DEFECT OCCLUDERS [C] . Yiming Li, Kun Sun, Chengli Song ASME Design of Medical Decices Conference . 2018

机译：心室间隔缺陷封闭剂的有限元建模与分析
5. Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving US Food and Drug Administration Premarket Approval in 2010 and 2011. [D] . Rathi, Vinay Kumar. 2016

机译：在2010年和2011年获得美国食品药品监督管理局上市前批准的高风险治疗性医疗器械整个产品生命周期中进行的临床研究。
6. Use of the Amplatzer muscular ventricular septal defect occluder for closure of perimembranous ventricular septal defects [O] . M Szkutnik, S A Qureshi, J Kusa, 2007

机译：Amplatzer肌室间隔缺损封堵器用于闭合膜周围室间隔缺损
7. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder Immediate and mid-term results of a U.S. registry [O] . Holzer Ralf, Balzer David, Cao Qi-Ling, 2004

机译：使用Amplatzer肌肉室间隔缺损封堵器封闭肌肉室间隔缺损美国登记处的即期和中期结果

First Food and Drug Administration approval under humanitarian device exemption of a septal occluder for fenestrated fontan and muscular ventricular septal defects (news)

著录项

相似文献

相关主题

期刊订阅